WO2002000240A3 - Compositions and methods for treating females sexual response - Google Patents

Compositions and methods for treating females sexual response Download PDF

Info

Publication number
WO2002000240A3
WO2002000240A3 PCT/US2001/041141 US0141141W WO0200240A3 WO 2002000240 A3 WO2002000240 A3 WO 2002000240A3 US 0141141 W US0141141 W US 0141141W WO 0200240 A3 WO0200240 A3 WO 0200240A3
Authority
WO
WIPO (PCT)
Prior art keywords
female sexual
relates
present
disorders
compositions
Prior art date
Application number
PCT/US2001/041141
Other languages
French (fr)
Other versions
WO2002000240A2 (en
Inventor
Martin G Crosby
Robert M Bennett
Original Assignee
Qualilife Pharmaceuticals Inc
Martin G Crosby
Robert M Bennett
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qualilife Pharmaceuticals Inc, Martin G Crosby, Robert M Bennett filed Critical Qualilife Pharmaceuticals Inc
Priority to AU2001273636A priority Critical patent/AU2001273636A1/en
Priority to CA2417552A priority patent/CA2417552C/en
Priority to EP01952931A priority patent/EP1328281B1/en
Priority to DE60130007T priority patent/DE60130007T2/en
Publication of WO2002000240A2 publication Critical patent/WO2002000240A2/en
Publication of WO2002000240A3 publication Critical patent/WO2002000240A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Abstract

The present invention relates to compositions, articles of manufacture, methods of preparation thereof, methods of use thereof, etc., for enhancement of sexual pleasure, conditions, disorders, and diseases related to reproductive physiology and systems, especially of mammalian females. For instance, the present invention relates to all aspects of modulating the female sexual response, including female sexual dysfunction, such as female sexual arousal disorders (FSAD), orgasmic disorders, and sexual pain disorders, and enhancing female sexual pleasure and satisfaction of the female sexual experience. Accordingly, the present invention relates to compositions comprising botanical extracts, active agents, etc., which are useful to treat or affect any of the aforementioned conditions. For example, the present invention relates to a composition, preferably for topical or local use, which comprises one or more of the following ingredients, including, but not limited to, borage seed oil, Angelica pubescens root and other angelica species, Coleus forskohlii extract, vinpocetine, ferulic acid, magnesium, ascorbyl palmitate, capric/caprylic triglyceride, silica, and equivalents thereof.
PCT/US2001/041141 2000-06-27 2001-06-27 Compositions and methods for treating females sexual response WO2002000240A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2001273636A AU2001273636A1 (en) 2000-06-27 2001-06-27 Compositions and methods for treating females sexual response
CA2417552A CA2417552C (en) 2000-06-27 2001-06-27 Compositions and methods for treating females sexual response
EP01952931A EP1328281B1 (en) 2000-06-27 2001-06-27 Compositions and methods for treating females sexual response
DE60130007T DE60130007T2 (en) 2000-06-27 2001-06-27 COMPOSITIONS AND METHODS FOR TREATING THE FEMALE SEXUAL REACTION

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21447200P 2000-06-27 2000-06-27
US60/214,472 2000-06-27

Publications (2)

Publication Number Publication Date
WO2002000240A2 WO2002000240A2 (en) 2002-01-03
WO2002000240A3 true WO2002000240A3 (en) 2003-09-25

Family

ID=22799196

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/041141 WO2002000240A2 (en) 2000-06-27 2001-06-27 Compositions and methods for treating females sexual response

Country Status (8)

Country Link
US (3) US6737084B2 (en)
EP (1) EP1328281B1 (en)
AT (1) ATE369868T1 (en)
AU (1) AU2001273636A1 (en)
CA (1) CA2417552C (en)
DE (1) DE60130007T2 (en)
ES (1) ES2291333T3 (en)
WO (1) WO2002000240A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000240A2 (en) 2000-06-27 2002-01-03 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response
US20060254597A1 (en) * 2000-12-14 2006-11-16 40J's Llc Method of treatment of atrophic vaginitis by topical clitoral menthol or a related cooling compound
GB0129987D0 (en) * 2001-12-14 2002-02-06 Zylepsis Ltd Skin compositions
GB0208704D0 (en) * 2002-04-16 2002-05-29 Futura Medical Dev Ltd Condom
AU2003238264B2 (en) * 2002-06-18 2009-05-21 Dsm Ip Assets B.V. Stable emulsions of oils in aqueous solutions and methods for producing same
ITMI20030661A1 (en) 2003-04-04 2004-10-05 Indena Spa PROCESS FOR THE PREPARATION OF FERUTININ FROM PLANTS OF THE GENE FERULA
ITMI20031428A1 (en) * 2003-07-11 2005-01-12 Indena Spa COMBINATIONS OF VASOACTIVE AGENTS AND THEIR USE FOR THE TREATMENT OF SEXUAL DYSFUNCTIONS
AU2004299058A1 (en) * 2003-12-12 2005-06-30 Aventis Pharmaceutical, Inc. Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
US20050187507A1 (en) * 2004-01-08 2005-08-25 Reed Andre' L. Method and apparatus for removal of menses, reduction of menses interference during coitus, and enhancement of sexual pleasure
EP1737448A1 (en) * 2004-03-22 2007-01-03 Myogen, Inc. (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
JP2007530566A (en) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド (R) -Enoximone sulfoxide and its use in the treatment of PDE-III mediated diseases
US6949067B1 (en) * 2004-05-11 2005-09-27 Dann Jeffrey A Device and method for enhancing female sexual stimulation
WO2006007213A1 (en) * 2004-06-23 2006-01-19 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
US8703198B2 (en) * 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
US20100233295A1 (en) * 2005-03-02 2010-09-16 Vibha Gupta Aqueous moisturizers and lubricants and uses thereof
GB0504547D0 (en) * 2005-03-04 2005-04-13 Delsol Products Ltd Personal lubricant
US20090041743A1 (en) * 2007-08-10 2009-02-12 Ma Te Lun Sperm-blocking agent composition with contraceptive effect
US20090054498A1 (en) * 2007-08-21 2009-02-26 Nawaz Ahmad Anhydrous Compositions Useful for Attaining Enhanced Sexual Wellness
US20090054497A1 (en) * 2007-08-21 2009-02-26 Nawaz Ahmad Methods for attaining enhanced sexual wellness using anhydrous compositions
US20090197892A1 (en) * 2007-08-21 2009-08-06 Nawaz Ahmad Anhydrous compositions useful for attaining enhanced sexual wellness
EP2446131A2 (en) * 2009-06-22 2012-05-02 Donaldson Company, Inc. Filter element support assembly, quick installation system, and methods
US20110002966A1 (en) * 2009-07-01 2011-01-06 Alex Lovett Vaginal Suppository System and Method
AR086400A1 (en) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp FORMULATIONS IN INTRANASAL GEL OF TESTOSTERONE IN DOSE OF LOWER POWER AND USE OF THE SAME FOR THE TREATMENT OF ANORGASMIA OR THE DISORDER OF HYPOACTIVE SEXUAL DESIRE
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
WO2012156821A1 (en) 2011-05-13 2012-11-22 Trimel Pharmaceuticals Corp. Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
KR20160020472A (en) * 2013-06-19 2016-02-23 액세스 비지니스 그룹 인터내셔날 엘엘씨 Plant-based inhibitors of ketohexokinase for the support of weight management
WO2015027201A1 (en) * 2013-08-22 2015-02-26 Baxco Pharmaceutical, Inc. Methods and compositions for enhancing female sexual wellness
CN103651359B (en) * 2013-11-26 2015-09-23 武汉天惠生物工程有限公司 Osthole biotic pesticide
US10226418B2 (en) 2014-05-12 2019-03-12 Susie Q, Ltd. Arginine-containing topical composition
CN104351181A (en) * 2014-10-28 2015-02-18 山东中大药业有限公司 Microcapsule suspension agent with effective ingredients including allicin and cnidium lactone
US20230041289A1 (en) * 2021-08-05 2023-02-09 Innovus Pharmaceuticals, Inc. Compositions and methods for enhancing or treating female sexual response

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000016752A2 (en) * 1998-09-18 2000-03-30 Lavipharm Laboratories, Inc. Transdermal devices comprising essential oils for aromatherapy
JP2000119156A (en) * 1998-10-14 2000-04-25 Kose Corp Skin lotion

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231022B2 (en) * 1972-10-06 1977-08-12
US4096238A (en) 1974-12-23 1978-06-20 Alza Corporation Method for administering drug to the gastrointestinal tract
DE2602297B1 (en) 1976-01-22 1977-01-13 Merz & Co VAGINAL SUPPLIES FOR CONCEPTION CONTAINING MILK ALBUMIN
DE2654796A1 (en) 1976-12-03 1978-06-08 Hoechst Ag POLYOXYGENATED LABDAN DERIVATIVES
US4076854A (en) * 1977-03-03 1978-02-28 International Flavors & Fragrances Inc. Flavoring with a cyclohexadiene derivative
US4393871A (en) 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4317447A (en) 1979-07-19 1982-03-02 Ortho Pharmaceutical Corporation Drug delivery system
US4475916A (en) 1982-03-18 1984-10-09 Merck & Co., Inc. Osmotic drug delivery system
EP0154756B2 (en) 1984-02-29 1996-10-23 Covex (S.A.) Citrate of vinpocetine, and process for its preparation
US4692441A (en) 1985-08-16 1987-09-08 Merck & Co., Inc. Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities
AU591196B2 (en) 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
US4858624A (en) 1988-02-24 1989-08-22 Vance Products Incorporated D/B/A/ Cook Urological Incorporated And Cook Ob/Gyn Device and method for intravaginal, barrier-type prevention of conception and infection
US4989618A (en) 1988-02-24 1991-02-05 Vance Products Incorporated Device and method for intravaginal, barrier-type prevention of conception and infection
US5207232A (en) 1988-02-24 1993-05-04 Alfred A. Shihata Device and method for intravaginal, barrier-type prevention of conception and infection
NO179479C (en) 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Process for the preparation of an intravaginal pharmaceutical preparation
US4873078A (en) * 1988-04-22 1989-10-10 Plough, Inc. High-gloss, high-shine lipstick
JP2628346B2 (en) * 1988-07-01 1997-07-09 株式会社トプコン Memory card storage
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5177207A (en) 1989-01-11 1993-01-05 Hoechst-Roussel Pharmaceuticals, Inc. 7-aryl and heteroaryl ethers of desacetylforskolin
US4999351A (en) 1989-01-11 1991-03-12 Hoechst-Roussel Pharmaceuticals, Inc. 7-aryl and heteroaryl ethers of desacetylforskolin
US5145855A (en) 1989-07-06 1992-09-08 Hoechst Roussel Pharmaceuticals, Inc. 6- and 7-deoxyforskolin and derivatives thereof
US5093336A (en) 1989-07-06 1992-03-03 Hoechat-Roussel Pharmaceuticals, Inc. 6- and 7-deoxyforskolin and derivatives thereof
FR2650952B1 (en) * 1989-08-17 1994-10-14 Lvmh Rech COSMETIC OR PHARMACEUTICAL COMPOSITION, ESPECIALLY DERMATOLOGICAL, CONTAINING AN EXTRACT OF COLLEUS AND PROCESS FOR THE PREPARATION THEREOF
EP0447962A1 (en) 1990-03-17 1991-09-25 Hoechst Aktiengesellschaft Labdanes and process for their preparation
EP0650723A3 (en) 1990-03-23 1995-08-30 Nippon Kayaku Kk Novel pharmaceutical use of forskolin derivatives.
US5350864A (en) 1990-05-03 1994-09-27 The United States Of America As Represented By The Department Of Health And Human Services Aminoalkylcarbamyl derivatives of forskolin as intermediates for the synthesis of useful forskolin derivatives
US5077274A (en) * 1990-10-12 1991-12-31 International Flavors & Fragrances Inc. Bicyclo[10.2.0]tetradecan-13-one, fragrance use thereof, process for preparing same and dichlorinated intermediate used in said process
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
MX9205850A (en) 1991-10-10 1993-06-01 Alza Corp PHARMACEUTICAL OSMOTIC ASSORTMENT DEVICES WITH HYDROPHOBIC WALL MATERIALS
JPH05194179A (en) * 1992-01-21 1993-08-03 Kanebo Ltd Skin cosmetic
US5393528A (en) 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
GB9211229D0 (en) 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
US5698589A (en) 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5310556A (en) * 1993-06-09 1994-05-10 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic composition
CN1097311A (en) 1993-07-14 1995-01-18 杨景信 The manufacture method that is used for sexual health care medication woman spring health ointment
US5565466A (en) 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
CN1104886A (en) * 1994-01-06 1995-07-12 田华琴 Skin caring cream for removing freckle comedo and wrinkle
US5731339A (en) 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
JPH08333266A (en) * 1995-06-09 1996-12-17 Masatoshi Yamada Medicine containing plant active ingredient and its use
US6036977A (en) 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US5690947A (en) * 1996-08-30 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
AU734734B2 (en) 1997-10-28 2001-06-21 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US5877216A (en) 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
US5945117A (en) 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
FR2777179A1 (en) * 1998-04-09 1999-10-15 Lvmh Rech Cosmetic and dermatological composition with non-greasy feel and useful as carrier
US5891915A (en) 1998-05-01 1999-04-06 Wysor; Michael S. Method for enhancing female sexual response and an ointment therefor
US6046240A (en) 1998-05-01 2000-04-04 Harvard Scientific Corporation Methods for treating female sexual dysfunction
US6007824A (en) 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
CN1237413A (en) * 1999-05-06 1999-12-08 马宏 Aloe face-beautifying cosmetics
AU5026600A (en) * 1999-05-18 2000-12-05 Procter & Gamble Company, The Methods of regulating the condition of mammalian keratinous tissue
WO2002000240A2 (en) 2000-06-27 2002-01-03 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000016752A2 (en) * 1998-09-18 2000-03-30 Lavipharm Laboratories, Inc. Transdermal devices comprising essential oils for aromatherapy
JP2000119156A (en) * 1998-10-14 2000-04-25 Kose Corp Skin lotion

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 200035, Derwent World Patents Index; Class B04, AN 2000-402930, XP002227972 *

Also Published As

Publication number Publication date
CA2417552C (en) 2014-05-13
WO2002000240A2 (en) 2002-01-03
US20040202739A1 (en) 2004-10-14
DE60130007T2 (en) 2008-04-30
CA2417552A1 (en) 2002-01-03
US20110117228A1 (en) 2011-05-19
US7875299B2 (en) 2011-01-25
ATE369868T1 (en) 2007-09-15
EP1328281A1 (en) 2003-07-23
AU2001273636A1 (en) 2002-01-08
US8128972B2 (en) 2012-03-06
US20020034557A1 (en) 2002-03-21
ES2291333T3 (en) 2008-03-01
US6737084B2 (en) 2004-05-18
EP1328281B1 (en) 2007-08-15
DE60130007D1 (en) 2007-09-27

Similar Documents

Publication Publication Date Title
WO2002000240A3 (en) Compositions and methods for treating females sexual response
Ming et al. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling
Quintans-Júnior et al. Antinociceptive activity and redox profile of the monoterpenes
Halder et al. Clove oil reverses learning and memory deficits in scopolamine-treated mice
BR0013897A (en) Use of conjugated linoleic acid (cla) or a derivative thereof, topical cosmetic or dermatological composition, and method of treatment and / or prophylaxis of cellulite and fat deposits
PT1100516E (en) MATRICARIA EXTRACTS (TANACETUM PARTHENIUM) AGAINST INFLAMMATORY DISEASES
CN108473484A (en) It can be used as the compound of TRPM8 conditioning agents
WO2007077541A3 (en) Cosmetic composition comprising glaucine and its use
Kumar et al. Anxiolytic activity of Indian Hypericum perforatum Linn: an experimental study
WO2006109898A8 (en) Antimicrobial composition containing natural extract, nano silver and natural essential oil
CA2227977A1 (en) Use in a composition of an extract of at least one labiate
BR0313983A (en) A compound comprising actinide arguta extract and related species for the prevention and treatment of allergic diseases and non-allergic inflammatory diseases.
WO2008048963A3 (en) Natural compositions for killing parasites on a companion animal
HUP0002806A2 (en) Taste modified hard confectionery compositions containing functional ingredients
RU2007125126A (en) COMPOSITION FOR REDUCING THE NUMBER OF FAT IN THE BODY
US20090269426A1 (en) Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions
WO1999058674A3 (en) Method of inhibiting osteoclast activity
WO2002026244A3 (en) Compositions and methods of use for extracts of rutaceae plants
MXPA06013179A (en) Anti acne skincare composition and skincare article.
WO2004087181A8 (en) ACTIVE INGREDIENT COMBINATIONS OF PLANT OILS CONTAINING ω3-FATTY ACIDS AND PLANT EXTRACTS CONTAINING POLYPHENOLS AND THE USE THEREOF
WO2004052294A3 (en) Compositions and methods related to lipid:emodin formulations
PT100668A (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING ALCOHOLIC EXTRACTS OF CORYDALIS AND ESCHSOLTZIA FOR USE IN THE TREATMENT OF AGITATION AND NERVE DISEASES
WO2003086274A3 (en) A compound for cleansing the skin and a product impregnated therewith
US20050100618A1 (en) Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of Icariin, a herbal product produced from the Epimedium genus of the Berberidaceal family of plants, for the treatment of sexual dysfunction
WO2010041908A3 (en) Novel use of panduratin derivative or boesenbergia pandurata extract

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001952931

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2417552

Country of ref document: CA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001952931

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWG Wipo information: grant in national office

Ref document number: 2001952931

Country of ref document: EP